XML 51 R27.htm IDEA: XBRL DOCUMENT v2.4.0.8
Sale of Sumavel DosePro Business Net Assets and Calculation of Gain on Sale (Details) (USD $)
In Thousands, unless otherwise specified
3 Months Ended 6 Months Ended 0 Months Ended 6 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Jun. 30, 2014
Jun. 30, 2013
Dec. 31, 2013
May 16, 2014
Sumavel DosePro [Member]
Jun. 30, 2014
Sumavel DosePro [Member]
May 16, 2014
Sumavel DosePro [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                
Non-contingent consideration received               $ 89,624
Imputed interest on working capital advance               4,748
Carrying value of Sumavel DosePro inventory on hand at Closing 4,874   4,874   1,112     (4,624)
Transaction costs               (660)
Deferred revenue associated with undelivered elements             (9,005) (9,108)
Net gain on sale of business $ 79,980 $ 0 $ 79,980 $ 0   $ 79,980 $ 79,980